Publications by authors named "Thomas Segerson"

Claim this Profile
V
Vardenafil restores erectile function to normal range in men with erectile dysfunction.
Harin Padma-Nathan, Francesco Montorsi, François Giuliano, Eric Meuleman, Stephen Auerbach, Thomas Segerson

J Sex Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age.
François Giuliano, Craig Donatucci, Francesco Montorsi, Stephen Auerbach, Gary Karlin, Thomas Segerson

BJU Int· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.
Wayne J G Hellstrom, Marc Gittelman, Gary Karlin, Thomas Segerson, Marc Thibonnier

J Androl· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.
Wayne J G Hellstrom, Marc Gittelman, Gary Karlin, Thomas Segerson, Marc Thibonnier

Urology· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.
Irwin Goldstein, Jay M Young, Jerome Fischer, Keith Bangerter, Thomas Segerson

Diabetes Care· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis